Characterization and Management of Paradoxical Upgrading Reactions in HIV-Uninfected Patients with Lymph Node Tuberculosis
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
In a retrospective analysis, paradoxical deterioration of lymph node tuberculosis in human immunodeficiency virus-uninfected patients was common, occurring in 25 (23%) of 109 patients after treatment had been given for a median of 46 days (interquartile range, 21-139 days) and persisting for a median of 67.5 days (interquartile range, 34-111 days). We found no association between the use of steroids and the duration of reaction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PURhas been reported in 20%-23% of HIV-negative patients [5, 49, 50].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [50]
In the citing paper
“Manifestations of PUR have included enlarging lymph nodes in 32%-68% of cases [50], new nodes in 27%-36%, pain in 60%, and draining sinuses in 12%60% [5, 49, 50].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [50]
In the citing paper
“Biopsy or culture of nodes involved in PUR typically shows granuloma formation and negative culture results with or without positive AFB stains [5, 50].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [50]
In the citing paper
“Only uncontrolled studies are available on treatment outcomes in adults with peripheral lymphadenitis [49, 50].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [50]
In the citing paper
“It occurred at a median of 1.5 months (46 days; interquartile range, 21-139 days) after initiation of treatment in a study from London and persisted for a median of 2 months (67 days; interquartile range, 34-111 days) [50].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [50]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
New England Journal of Medicine
(2010) · Wilderness & Environmental Medicine · doi:10.1016/j.wem.2010.09.014 · Cited by 602
A RATIONAL APPROACH FOR ASSESSING THE HYPOTHALAMO-PITUITARY-ADRENAL AXIS
Stewart, P. M., Seckl, J. R., Corrie, J., Edwards, C. R. W., & Padfield, P. L. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92020-x · Cited by 418
Afghani, B., & Lieberman, J. M. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.6.1092 · Cited by 270 · cited 1×
“Furthermore, PURs have occurred in patients who were given steroids from the outset of their anti-TB treatment [9, 10], and another report has provided details about PURs that resolved without steroid treatment [2].”
BackgroundImmune reconstitution inflammatory syndrome
BRETON, G. (2009) · Tuberculosis · doi:10.1016/b978-1-4160-3988-4.00067-6 · Cited by 206
PARADOXICAL EXPANSION OF INTRACRANIAL TUBERCULOMAS DURING CHEMOTHERAPY
Chambers, S. T., Record, C., Hendrickse, W. A., Rudge, P., & Smith, H. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90478-1 · Cited by 195
Lymph node tuberculosis: A comparison of various methods of treatment
Campbell, I. A., & Dyson, A. J. (1977) · Tubercle · doi:10.1016/0041-3879(77)90041-1 · Cited by 189
CEREBRAL TUBERCULOMAS DEVELOPING DURING TREATMENT OF TUBERCULOUS MENINGITIS
Lees, A. J., Macleod, A. F., & Marshall, J. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91676-1 · Cited by 104
Hejazi, N. A., & Hassler, W. (1997) · Infection · doi:10.1007/bf01713151 · Cited by 78
[The Revue des Maladies Respiratoires].
Taytard, A. (1990) · PubMed · Cited by 75
Needle aspiration for suppurative post-BCG adenitis.
Banani, S. A., & Alborzi, A. (1994) · Archives of Disease in Childhood · doi:10.1136/adc.71.5.446 · Cited by 62
Carter, E. J., & Mates, S. (1994) · CHEST Journal · doi:10.1378/chest.106.6.1896 · Cited by 35
Safdar, A., Brown, A. E., Kraus, D. H., & Malkin, M. (2000) · Clinical Infectious Diseases · doi:10.1086/313731 · Cited by 25
Central nervous system tuberculosis in Australia: a report of 22 cases
Watson, J. D. G., Shnier, R. C., & Seale, J. P. (1993) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb121837.x · Cited by 23
Duray, P. H., Flannery, B. L., & Brown, S. P. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107163050312 · Cited by 21
[Needle aspiration in paradoxical hypertrophy of tuberculous lymphadenitis].
Meybeck, A., Just, N., Nyunga, M., Bourahla, M., & Wallaert, B. (2003) · PubMed · Cited by 6
Research works printed but not linked: 1
- Shelburne, 2003, AIDS reviews, 5, 67
Cited by
Meintjes, G., Lawn, S. D., Scano, F., Maartens, G., French, M. A., Worodria, W., Elliott, J. H., Murdoch, D., Wilkinson, R. J., Seyler, C., et al. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70184-1 · Cited by 745
Self-citationHost Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
Tobin, D. M., Roca, F. J., Oh, S. F., McFarland, R., Vickery, T. W., Ray, J. P., Ko, D. C., Zou, Y., Bang, N. D., Chau, T. T. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.023 · Cited by 580
Current diagnosis and management of peripheral tuberculous lymphadenitis.
Fontanilla, J.-M., Barnes, A., & von Reyn, C. F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir454 · Cited by 299
Maartens, G., & Wilkinson, R. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61262-8 · Cited by 245
Self-citationA wearable haemodialysis device for patients with end-stage renal failure: a pilot study
Davenport, A., Gura, V., Ronco, C., Beizai, M., Ezon, C., & Rambod, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61864-9 · Cited by 217
Metadata
- Authors
- Hawkey, C. R., Yap, T., Pereira, J., Moore, D. A. J., Davidson, R. N., Pasvol, G., Kon, O. M., Wall, R. A., & Wilkinson, R. J.
- Affiliations
- National Health Service (GB)
- St Mary's Hospital (GB)
- Imperial College London (GB)
- Corresponding author
- Wilkinson, R. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-05-01
- Volume
- 40
- Issue
- 9
- Pages
- 1368-1371
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2128600869
- Cited by
- 170
- References
- 15
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 7 · 2023: 7 · 2022: 8 · 2021: 5 · 2020: 8 · 2019: 12 · 2018: 10 · 2017: 9 · 2016: 14 · 2015: 11 · 2014: 7 · 2013: 6 · 2012: 9
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- paradoxical reaction, tuberculous lymphadenitis, HIV-negative patients, tuberculosis treatment, steroid use, treatment duration, disease deterioration
- MeSH terms
- Adolescent, Adrenal Cortex Hormones, Adult, Aged, Aged, 80 and over, Antitubercular Agents, Child, Child, Preschool, Female, Humans, Male, Middle Aged, Retrospective Studies, Tuberculosis, Lymph Node
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.